CIPO trademark

TEVA Logo B&W

RegisteredCIPOFigurative markClass 1Class 3Class 5Class 9+4

"TEVA Logo B&W" is a figurative mark owned by Teva Pharmaceutical Industries Ltd., filed at the CIPO on February 23, 2016. It is registered and covers classes 1, 3, 5, 9, 10, 16, 35 and 42.

Official CIPO record
TEVA Logo B&W trademark as filed
As filed with the CIPO
Status
Registered
Since January 24, 2020
Filed
February 23, 2016
Registered
January 24, 2020
Expires
January 24, 2030
Application no.
1768984
Registration no.
TMA1070739
Office
CIPO
Canadian Intellectual Property Office
Mark type
Figurative mark
8 classes
Ownership

Who owns TEVA Logo B&W

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceutical Industries Ltd.

Israel

1,141 trademarks in the portfolioView company

Representative

Osler, Hoskin & Harcourt LLP

Osler, Hoskin & Harcourt LLP

Goods and services

What the mark covers

The products and services TEVA Logo B&W is filed for, grouped by Nice class.

  • Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations.

  • Bleaching preparations and detergents for laundry use; cleaning, polishing, scouring and abrasive preparations for cleaning medical instruments; soaps, namely, anti-bacterial soaps, disinfectant soaps and industrial soaps; perfumery; cosmetics hair lotions; dentifrices.

  • Pharmaceutical preparations, prescription and over-the-counter, namely, acne medications, allergy medications, alopecia medications, anabolics, analgesics, anesthetics, antacids, anorectics, anthelmintics, antianaemics, anti-anaemia drugs, antianginals, antiarrhythmics, antibacterials, antibiotics, antibiotic creams and ointments, anticoagulants, anticonvulsants, antidepressants, antidiabetics, antidiarrhoeals, antidotes to counteract opioids and to treat overdoses of folic acid antagonists and iron overloading; antiemetics, anti-arthritis medications, anti-epileptics, antifibrinolytics, antiflatulents, antifungals, antigout medications, antihistamines, antihypertensives, anti-infectives, anti-inflammatories, antileprotics, antimalarials, anti-obesity medications, antiparasites, anti-parkinsonians, antipsoriasis medications, antipyretics, antirheumatic medications, anti-sickling medications, anti-smoking agents, antispasmodics, antithrombotics, antitussive medications, antiulcer medications, antivirals, appetite stimulants, appetite suppressants, asthma medications, autonomic agents, beta blockers, bone metabolism regulators, bronchodilators, burn relief medications, calcium channel blockers, calcium metabolism regulators, cancer and antineoplastic medications, central nervous system depressants, central nervous system stimulants, cough medications, cardioglycoside, cardiostimulents, cardiovascular drugs, cholagogues, cholesterol lowering agents, contraceptive medications, corticosteroids, gastro-intestinal medications, diuretics, fibrinolytics, emollients, expectorants, gastro-intestinal medications, gastroprokinetics, glaucoma medications, haemostatics, haemotological medications, hepatoprotectors, hormonal medications for use in hormone replacement therapy and in the treatment of cancer; human growth hormones; hydrocortisone, hypolipaemics, hypnotic agents, immunoglobulins, immunomodulators, immunosuppressants, impotence and sexual dysfunction medications, incontinence medications, infertility drugs, insomnia medications, insulin, iron, laxatives, liver extract, migraine medications, medications for balancing electrolytic, caloric and water levels, medications for preventing and treating sequelae of oncologic diseases and their treatment, namely, nausea and vomiting, hematologic depression, mucositis, cachexia, pain and bone pain and fatigue, medications for treating dermatological diseases and disorders, namely, dermatitis, skin and skin structure diseases, infections and injuries, psoriasis, eczema and sexually transmitted diseases, medications for treating ocular motility disorders, medications for treating neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, medications for treating obesity and weight loss and for weight management, medications for treating psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses, medications for treating renal and cardio-renal diseases, medications for preventing and treating respiratory diseases and their symptoms, medications for treating sexually transmitted diseases, mineral supplements, muscular dystrophy medications, mucolytics, muscle relaxants, multiple sclerosis medications, narcotic agents, narcotic antagonists, nasal decongestants, neuroleptics, non-steroidal anti-inflammatory drugs (NSAIDS), opiods, opthalmological drugs, otological drugs, osteoporosis medications, plasma substitutes and blood fractions, plasmodicides, psychotherapeutic and psychotropic agents, restless leg medications, sedatives, tuberculostatics, vasodilators, vasoprotective medications, vitamins, vulnerary medications, human vaccines.

  • Downloadable software in the nature of mobile applications, computer application software and computer software, all for use in medical diagnosis, namely to assist doctors with making differential diagnoses, in medical imaging, for providing educational information and instruction in healthcare, pharmaceuticals and pharmacy, and for managing patient care and patient records.

  • Surgical instruments; dental instruments; veterinary instruments.

  • Printed publications, namely, books, hand-outs, workbooks, and journals, featuring information regarding allergies, the treatment thereof, and patient services for allergies.

  • Management of business affairs and commercial functions of an enterprise in the pharmaceutical industry, namely personnel recruitment, personnel management consultancy and accounting services, business research relating to the development of new products and business opportunities, and marketing research.

  • Research services in the field of pharmaceuticals; consulting services pertaining to pharmacology.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Voir Preuve au dossier/See evidence on File No. 2121983
  2. Amendment to Registration; Owner Address Change / Voir Preuve au dossier/See evidence on File No. 2121983
  3. Registered
  4. Extension of Time; Online Request Date: 2019/06/11
  5. Extension of Time; Online Request Date: 2019/01/28
  6. Agent Changed; From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341
  7. Rep for Service Changed; From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341
  8. Allowance Notice Sent
  9. Allowed
  10. Advertised; Vol.64 Issue 3296

9 earlier steps on the official record.

FAQ

About TEVA Logo B&W

Who owns the trademark "TEVA Logo B&W"?

The CIPO trademark "TEVA Logo B&W" (application 1768984) is owned by Teva Pharmaceutical Industries Ltd.

What is the status of "TEVA Logo B&W"?

Its status at the CIPO is: registered.

When was "TEVA Logo B&W" registered?

It was registered on January 24, 2020 and is due to expire on January 24, 2030.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull TEVA Logo B&W and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019deb52-f6a1-77d2-bd1e-9efcd2533ff1
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb52-f6a1-77d2-bd1e-9efcd2533ff1",
  "object": "trademark",
  "mark_text": "TEVA Logo B&W",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "1768984",
  "filing_date": "2016-02-23",
  "nice_classes": [
    1,
    3,
    5,
    9,
    10,
    16,
    35,
    42
  ],
  "owners": [
    {
      "name": "Teva Pharmaceutical Industries Ltd.",
      "entity_id": "ent_019ebbc5-6f32-7092-a649-5aaa7b712e21"
    }
  ]
}